Cargando…
Is Estradiol a Biomarker of Type 2 Diabetes Risk in Postmenopausal Women?
Autor principal: | Mauvais-Jarvis, Franck |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319722/ https://www.ncbi.nlm.nih.gov/pubmed/28223340 http://dx.doi.org/10.2337/dbi16-0063 |
Ejemplares similares
-
Early Menopause and Cardiovascular Disease Risk in Women With or Without Type 2 Diabetes: A Pooled Analysis of 9,374 Postmenopausal Women
por: Yoshida, Yilin, et al.
Publicado: (2021) -
Estrogen Sulfotransferase: Intracrinology Meets Metabolic Diseases
por: Mauvais-Jarvis, Franck
Publicado: (2012) -
Novel Link Between Inflammation, Endothelial Dysfunction, and Muscle Insulin Resistance
por: Mauvais-Jarvis, Franck
Publicado: (2013) -
Estradiol, Progesterone, Immunomodulation, and COVID-19 Outcomes
por: Mauvais-Jarvis, Franck, et al.
Publicado: (2020) -
The D-Day of ghrelin
por: Tong, Jenny, et al.
Publicado: (2016)